Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5449]
News [12650]
Articles [175]
Editorials [5]
Conferences [248]
elearning [17]
Recent developments in neoadjuvant therapy
Prof Gunter Von Minckwitz – German Breast Group, Neu-Isenburg, Germany
Recent developments in neoadjuvant therapy ( Prof Gunter Von Minckwitz – German Breast Group, Neu-Isenburg, Germany )
17 May 2012
Highlights and goals of IMPAKT 2012
Prof Martine Piccart – Jules Bordet Institute, Brussels, Belgium
Highlights and goals of IMPAKT 2012 ( Prof Martine Piccart – Jules Bordet Institute, Brussels, Belgium )
17 May 2012
PI3K and the heterogeneity of small tumour breast cancer
Dr Sherene Loi – Jules Bordet Institute, Brussels, Belgium
PI3K and the heterogeneity of small tumour breast cancer ( Dr Sherene Loi – Jules Bordet Institute, Brussels, Belgium )
17 May 2012
Molecularly characterising triple negative breast cancer
Prof Jorge Reis-Filho – Jules Bordet Institute, Brussels, Belgium
Molecularly characterising triple negative breast cancer ( Prof Jorge Reis-Filho – Jules Bordet Institute, Brussels, Belgium )
17 May 2012
Endocrine therapy and endocrine resistant breast cancer
Prof Mitch Dowsett – The Institute for Cancer Research, London, UK
Endocrine therapy and endocrine resistant breast cancer ( Prof Mitch Dowsett – The Institute for Cancer Research, London, UK )
17 May 2012
Neoadjuvant therapy and PCR through chemotherapy prior to surgery
Dr Michail Ignatiadis – Jules Bordet Institute, Brussels, Belgium
Neoadjuvant therapy and PCR through chemotherapy prior to surgery ( Dr Michail Ignatiadis – Jules Bordet Institute, Brussels, Belgium )
17 May 2012
Minimising recurrence by using most effective treatment
Prof Fabrice Andre – Institut Gustave Roussy, Paris, France
Minimising recurrence by using most effective treatment ( Prof Fabrice Andre – Institut Gustave Roussy, Paris, France )
17 May 2012
Targeting the PI3K/mTOR pathway
Dr Lewis Cantley – Dana-Farber Cancer Institute, Boston, USA
Targeting the PI3K/mTOR pathway ( Dr Lewis Cantley – Dana-Farber Cancer Institute, Boston, USA )
17 May 2012
Use of metformin against breast cancer
Prof Alastair Thompson – University of Dundee, UK
Use of metformin against breast cancer ( Prof Alastair Thompson – University of Dundee, UK )
17 May 2012
Advances in radiation oncology
Prof Guy Storme – University of Brussels, Belgium
Advances in radiation oncology ( Prof Guy Storme – University of Brussels, Belgium )
16 May 2012
Effects of lifestyle change in cancer patients
Prof Cornelia Ulrich – National Center for Tumor Diseases, Heidelberg, Germany
Effects of lifestyle change in cancer patients ( Prof Cornelia Ulrich – National Center for Tumor Diseases, Heidelberg, Germany )
16 May 2012
Involving patients in care decisions
Dr Vikki Entwistle – University of Dundee, UK
Involving patients in care decisions ( Dr Vikki Entwistle – University of Dundee, UK )
11 May 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation